721: IMMUNOMODULATOR WITHDRAWAL FROM ANTI-TNF THERAPY IS NOT ASSOCIATED WITH LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE
Remi Mahmoud(University Medical Center Utrecht), Bas Oldenburg(University Medical Center Utrecht), Michiel T. van der Kaaij(University Medical Center Utrecht), Boris P. van Hellemondt(University Medical Center Utrecht), J Schultheiss(University Medical Center Utrecht), Nofel Mahmmod(St. Antonius Ziekenhuis), Bindia Jharap(Meander Medisch Centrum), Petra G. Van Boeckel(St. Antonius Ziekenhuis), Herma H. Fidder(University Medical Center Utrecht), J Louwers(University Medical Center Utrecht)
Cited by 0
Related Papers
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial
|The Lancet Oncology|2011|470
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252